- Daiichi Sankyo, Inc. (Bernards, NJ)
- …well as other research areas centered around rare diseases and immune disorders.SummaryThe Director, Clinical Safety, will be a product safety lead or part of a ... and provide safety leadership including but not limited to clinical studies, post-marketing surveillance, signal detection and management, important safety… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Merck & Co. (Rahway, NJ)
- …the worldTravel on company business about twenty (20) percent of the time to manage future or ongoing clinical research projects. QualificationsEducation:M.D ... strive to create an environment of mutual respect, encouragement, and teamwork. As part of our global team, you'll have the opportunity to collaborate with talented… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Merck & Co. (Rahway, NJ)
- …and execute design verification strategies that successfully supports the clinical instruction(s) and commercial market approval(s) of combination products.Principal ... strategies for assigned drug-device combination product program(s) for successful clinical introduction(s) and commercial market(s) approval(s).Define design input(s)/ output(s)… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
- Formation Bio (New York, NY)
- …candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately ... capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs...values, and every team and individual plays a key part in our mission to bring new treatments to… more
